Escalon Medical (ESMC) Stock Price

Escalon Medical Price

OTC·CLOSED
0.18USD+0.00 (+0.00 %)
Market closed

Revenue at Escalon Medical has contracted by 4.7% per year over the past 19 years to 12.05 M USD. Escalon Medical's net margin stands at 0.9%, up from -0.5% several years earlier. The stock trades about 52% above its 52-week low.

Escalon Medical stock price

Volume
Details

Stock Price

How to Read This Chart

This chart tracks the historical stock price of Escalon Medical over time. You can switch between daily, weekly, and monthly views and select custom time ranges — from a single day to the full available history. Use the toggle to view price changes in absolute currency terms or as a percentage change relative to the starting date.

Total Return vs. Price Return

The "Total Return" toggle includes reinvested dividends on top of the pure price movement. This is critical because dividends can account for a significant portion of long-term returns. Historically, roughly 40 % of the S&P 500's total return has come from dividends. Always compare total return when evaluating a stock's real performance against a benchmark.

Intraday Price Data

When viewing a one-day time frame, the chart displays real-time intraday price movements. This is useful for observing how Escalon Medical stock reacts to market openings, earnings releases, or breaking news throughout the trading session.

What to Look For

Look for long-term trends (sustained upward or downward movements over months and years), support and resistance levels (price zones where the stock repeatedly bounces or reverses), and volatility (how much the price fluctuates day to day). Comparing Escalon Medical's price chart to a market index like the S&P 500 can reveal whether the stock is outperforming or underperforming the broader market.

Escalon Medical Stock Price History
DateEscalon Medical Price
8/21/20260.18 USD
8/20/20260.18 USD
8/19/20260.17 USD
8/18/20260.17 USD
8/17/20260.20 USD
8/14/20260.20 USD
8/13/20260.17 USD
8/12/20260.17 USD
8/11/20260.18 USD
8/10/20260.19 USD
8/7/20260.19 USD
8/6/20260.19 USD
8/5/20260.19 USD
8/4/20260.19 USD
8/3/20260.19 USD
7/31/20260.19 USD
7/30/20260.18 USD
7/29/20260.18 USD
7/27/20260.20 USD
7/23/20260.20 USD
7/22/20260.20 USD
7/21/20260.20 USD
7/20/20260.20 USD
7/17/20260.20 USD
7/16/20260.18 USD
7/15/20260.18 USD
7/14/20260.19 USD
7/13/20260.19 USD
7/10/20260.19 USD
7/9/20260.19 USD
7/8/20260.19 USD
7/7/20260.19 USD
7/6/20260.19 USD
7/2/20260.19 USD
7/1/20260.19 USD
6/30/20260.20 USD
6/29/20260.19 USD
6/26/20260.18 USD
6/25/20260.18 USD
6/24/20260.18 USD
6/23/20260.18 USD
6/22/20260.18 USD
6/18/20260.18 USD
6/17/20260.20 USD
6/16/20260.20 USD
6/15/20260.20 USD
6/12/20260.20 USD
6/11/20260.20 USD
6/10/20260.19 USD
6/9/20260.19 USD
6/8/20260.19 USD
6/5/20260.19 USD
6/4/20260.21 USD
6/3/20260.21 USD
6/2/20260.20 USD
6/1/20260.20 USD
5/29/20260.20 USD
5/28/20260.21 USD
5/27/20260.19 USD
5/26/20260.21 USD
5/22/20260.21 USD
5/21/20260.21 USD
5/20/20260.21 USD
5/19/20260.23 USD
5/18/20260.25 USD
5/15/20260.25 USD
5/14/20260.26 USD
5/13/20260.26 USD
5/12/20260.17 USD
5/11/20260.17 USD
5/8/20260.17 USD
5/7/20260.17 USD
5/6/20260.17 USD
5/5/20260.17 USD
5/4/20260.17 USD
5/1/20260.17 USD
4/30/20260.17 USD
4/28/20260.17 USD
4/21/20260.17 USD
4/16/20260.17 USD
4/15/20260.17 USD
4/14/20260.21 USD
4/2/20260.16 USD
4/1/20260.14 USD
3/31/20260.18 USD
3/27/20260.16 USD
3/26/20260.20 USD
3/18/20260.19 USD
3/17/20260.21 USD
3/16/20260.20 USD
3/9/20260.25 USD
3/6/20260.23 USD
3/4/20260.23 USD
3/3/20260.21 USD
3/2/20260.25 USD
2/27/20260.25 USD
2/26/20260.24 USD
2/23/20260.25 USD
2/19/20260.21 USD
2/17/20260.17 USD
2/13/20260.19 USD
2/12/20260.19 USD
2/11/20260.17 USD
2/10/20260.19 USD
2/4/20260.18 USD
2/3/20260.18 USD
2/2/20260.18 USD
1/30/20260.17 USD
1/29/20260.16 USD
1/28/20260.16 USD
1/27/20260.16 USD
1/23/20260.16 USD
1/6/20260.16 USD
12/31/20250.17 USD
12/30/20250.17 USD
12/19/20250.17 USD
12/18/20250.15 USD
12/17/20250.15 USD
12/15/20250.14 USD
12/12/20250.14 USD
12/1/20250.16 USD
11/28/20250.17 USD
11/26/20250.17 USD
11/21/20250.16 USD
11/20/20250.16 USD
11/14/20250.17 USD
11/13/20250.17 USD
11/10/20250.16 USD
11/7/20250.16 USD
11/4/20250.16 USD
11/3/20250.15 USD
10/31/20250.16 USD
10/30/20250.16 USD
10/27/20250.15 USD
10/24/20250.16 USD
10/23/20250.16 USD
10/22/20250.18 USD
10/17/20250.18 USD
10/16/20250.16 USD
10/15/20250.16 USD
10/14/20250.16 USD
10/9/20250.16 USD
10/8/20250.16 USD
10/7/20250.15 USD
10/6/20250.15 USD
10/3/20250.15 USD
10/2/20250.14 USD
10/1/20250.12 USD
9/30/20250.17 USD
9/25/20250.17 USD
9/24/20250.19 USD
9/19/20250.14 USD
9/18/20250.14 USD
9/17/20250.18 USD
9/16/20250.12 USD
9/15/20250.18 USD
9/12/20250.19 USD
9/11/20250.19 USD
9/9/20250.17 USD
9/8/20250.15 USD
9/5/20250.17 USD
9/4/20250.17 USD
8/28/20250.15 USD
8/27/20250.16 USD
Access this data via the Eulerpool API

Escalon Medical Revenue, EBIT, Net Income

  • 3 Years

  • 5 Years

  • 10 Years

  • 25 Years

  • Max

Revenue
EBIT
Net Income
Details
Date
Revenue
EBIT
Net Income
Jan 1, 2018
11.40 M USD
204,720.00 USD
583,675.00 USD
Jan 1, 2019
9.63 M USD
-252,955.00 USD
-250,016.00 USD
Jan 1, 2020
9.40 M USD
-794,657.00 USD
-650,280.00 USD
Jan 1, 2021
10.47 M USD
-33,697.00 USD
-52,023.00 USD
Jan 1, 2022
10.70 M USD
-470,063.00 USD
18,081.00 USD
Jan 1, 2023
12.18 M USD
478,543.00 USD
456,826.00 USD
Jan 1, 2024
11.98 M USD
-104,476.00 USD
-125,261.00 USD
Jan 1, 2025
12.05 M USD
133,217.00 USD
105,525.00 USD

Escalon Medical Income Statement, Balance Sheet, Cash Flow Statement

Last updated Aug 26, 2026, 8:29 AM
 
REVENUEM USD
REVENUE GROWTH%
GROSS MARGIN%
GROSS INCOMEM USD
EBITM USD
EBIT MARGIN%
NET INCOMEM USD
NET INCOME GROWTH%
SHARESM
2010201120122013201420152016201720182019202020212022202320242025
31.0029.0024.0011.0012.0013.0011.0011.0011.009.009.0010.0010.0012.0011.0012.00
-8.82-6.45-17.24-54.179.098.33-15.38-18.1811.1120.00-8.339.09
48.3944.8337.5045.4550.0046.1545.4545.4545.45-44.4444.4440.0040.0041.6745.4541.67
15.0013.009.005.006.006.005.005.005.00-4.004.004.004.005.005.005.00
-2.00-1.00-1.00-1.00
-8.33-9.09-7.69-9.09
-5.002.00-1.00
-140.00
3.153.153.153.153.153.153.153.153.153.153.153.153.153.153.153.15
Details

Income Statement Key Figures

Revenue and Revenue Growth

Revenue is the starting point of every income statement — it measures the total sales Escalon Medical generates from its core business. Revenue growth (expressed as year-over-year percentage change) is one of the most important indicators of business momentum. Sustained growth above 10 % annually is generally considered strong, while declining revenue is a serious warning sign that demands investigation.

Gross Margin

Gross margin = (Revenue − Cost of Goods Sold) ÷ Revenue. It reveals what percentage of each dollar of revenue Escalon Medical retains after direct production costs. High gross margins (above 50 %) are typical of asset-light businesses like software and brands, while capital-intensive industries like manufacturing often operate below 30 %. Compare Escalon Medical's gross margin to industry peers and track it over time to spot improving or deteriorating pricing power.

EBIT and EBIT Margin

EBIT measures operating profit — what remains after subtracting all operating expenses (including R&D, sales, and administrative costs) from gross profit. The EBIT margin shows this as a percentage of revenue. Because it excludes interest and taxes, EBIT allows fair comparisons between companies with different debt levels and tax jurisdictions. A rising EBIT margin indicates improving operational efficiency.

Net Income and Earnings Per Share (EPS)

Net income is the company's final profit after all expenses, interest, and taxes. Dividing net income by the number of shares outstanding gives you EPS — the single most influential metric in stock valuation. Consistent EPS growth is the primary driver of long-term stock price appreciation. Always check whether EPS growth comes from genuine profit improvement or from share buybacks reducing the share count.

Shares Outstanding

The total number of shares Escalon Medical has issued. A declining share count (through buybacks) boosts EPS and signals management confidence. A rising share count (through stock issuance) dilutes existing shareholders. Always monitor this number alongside EPS to get the full picture of per-share value creation.

Analyst Estimates

The projected figures represent consensus estimates from professional analysts. Compare these forecasts against Escalon Medical's historical growth rates to assess whether expectations are realistic. A company that consistently beats consensus estimates tends to see its stock price rewarded over time, while repeated misses erode investor confidence.

Escalon Medical stock margins

The Escalon Medical margin analysis displays the gross margin, EBIT margin, as well as the profit margin of Escalon Medical. The EBIT margin (EBIT/sales) indicates the percentage of sales that remains as operating profit. The profit margin shows the percentage of sales that remains for Escalon Medical.
  • 3 Years

  • 5 Years

  • 10 Years

  • 25 Years

  • Max

Gross margin
EBIT margin
Profit margin
Details
Date
Gross margin
EBIT margin
Profit margin
Jan 1, 2018
44.75 %
1.80 %
5.12 %
Jan 1, 2019
-51.91 %
-2.63 %
-2.60 %
Jan 1, 2020
44.70 %
-8.45 %
-6.92 %
Jan 1, 2021
42.28 %
-0.32 %
-0.50 %
Jan 1, 2022
43.04 %
-4.39 %
0.17 %
Jan 1, 2023
45.00 %
3.93 %
3.75 %
Jan 1, 2024
42.95 %
-0.87 %
-1.05 %
Jan 1, 2025
45.75 %
1.11 %
0.88 %

Escalon Medical Stock Revenue, EBIT, Earnings per Share

The Escalon Medical earnings per share therefore indicates how much revenue Escalon Medical has generated per share in a given period. The earnings before interest and taxes per share shows how much of the operating profit corresponds to each share. The earnings per share indicates how much of the profit belongs to each share.
  • 3 Years

  • 5 Years

  • 10 Years

  • 25 Years

  • Max

Details
Date
Revenue per Share
EBIT per share
Earnings per Share
Jan 1, 2018
0.00 USD
0.00 USD
0.00 USD
Jan 1, 2019
0.00 USD
0.00 USD
0.00 USD
Jan 1, 2020
0.00 USD
0.00 USD
0.00 USD
Jan 1, 2021
0.00 USD
0.00 USD
0.00 USD
Jan 1, 2022
0.00 USD
0.00 USD
0.00 USD
Jan 1, 2023
0.00 USD
0.00 USD
0.00 USD
Jan 1, 2024
0.00 USD
0.00 USD
0.00 USD
Jan 1, 2025
0.00 USD
0.00 USD
0.00 USD

Escalon Medical business model & stock analysis

Escalon Medical Corp is an American company specializing in the development, manufacturing, and marketing of specialized medical products and technological solutions. It was founded in 1987 and is headquartered in Wayne, Pennsylvania, USA. The company's business model focuses on the development and marketing of specialized medical products in various areas such as ophthalmic diagnostics, surgical instruments, intraocular lenses, parts and accessories, as well as the development of software systems and services. It has a long history of innovation in medicine to develop the latest technologies and products that meet the needs of medical offices and hospitals. The different business areas of Escalon Medical Corp include ophthalmic diagnostics, surgical instruments, intraocular lenses, parts and accessories, as well as the development of software systems and services. In ophthalmic diagnostics, the company offers a wide range of diagnostic systems including tonometry, perimetry, autorefraction, and ultrasound, which aid doctors in diagnosing eye conditions. In surgical instruments, Escalon Medical Corp manufactures a variety of instruments like scalpel handles, forceps, and scissors, designed for precise surgical procedures and improved outcomes for patients. The company also produces intraocular lenses for cataract surgery, offering a range of lenses including monofocal and multifocal lenses that provide enhanced vision and clarity for patients. Its replacement parts and accessories are specifically designed and manufactured for ophthalmic devices and surgical instruments, ensuring improved performance and extended lifespan of medical equipment. Additionally, Escalon Medical Corp has developed software systems and services to help doctors enhance performance, diagnosis, and treatment of patients. The software systems also provide effective digital documentation, aiding doctors in record management and compliance with regulations. In summary, Escalon Medical Corp is an established American company with years of experience in the development and manufacturing of medical products and solutions. With its wide range of products and services tailored to the needs of doctors and patients, the company is a trusted partner in the healthcare industry.

Escalon Medical SWOT Analysis

Strengths

Escalon Medical Corp has several strengths that contribute to its competitive advantage in the market. These include:

  • Strong product portfolio: Escalon offers a diverse range of medical products, including ophthalmic diagnostic instruments, surgical devices, and pharmaceuticals.
  • Established market presence: The company has a long-standing presence in the medical industry, with a well-known brand and a loyal customer base.
  • Research and development capabilities: Escalon invests in ongoing research and development to innovate and improve its product offerings, staying ahead of competitors.
  • Effective distribution network: The company has a wide network of distributors and partners, enabling efficient product delivery and market reach.

Weaknesses

Despite its strengths, Escalon Medical Corp also faces certain weaknesses, which it should address to remain competitive:

  • Dependency on a limited number of customers: Escalon relies heavily on a few key customers for a significant portion of its revenue, creating vulnerability to their decisions and market conditions.
  • Relatively small market share: The company operates in a highly competitive industry, and its market share is relatively smaller compared to some of its larger competitors.
  • Limited geographical presence: Escalon's operations are primarily focused in certain regions, limiting its exposure to potential markets and growth opportunities.
  • Dependency on key suppliers: The company relies on specific suppliers for critical components, which may lead to supply chain disruptions or increased costs if alternatives are not readily available.

Opportunities

Escalon Medical Corp can leverage the following opportunities to expand and enhance its business:

  • Increasing demand for advanced medical technologies: The rising need for efficient diagnostic and surgical instruments presents opportunities for Escalon to develop and market innovative products.
  • Expanding into emerging markets: There is potential for the company to enter new geographic markets with growing healthcare infrastructure and demand.
  • Strategic partnerships and acquisitions: Collaborating with other companies or acquiring complementary businesses can help Escalon broaden its product portfolio and market reach.
  • Focus on telehealth and remote monitoring: With the increasing adoption of telehealth solutions, Escalon can develop solutions to meet the evolving needs of healthcare providers and patients.

Threats

Escalon Medical Corp should be aware of the following threats, which could impact its performance and market position:

  • Intense competition: The medical industry is highly competitive, with numerous established players and new entrants, which can potentially erode Escalon's market share.
  • Changing regulatory environment: Evolving regulations and policies in the healthcare sector may introduce compliance challenges and affect the availability or reimbursement of certain products.
  • Economic downturns: During economic downturns, reduced healthcare spending and budget constraints can impact Escalon's sales and profitability.
  • Technological advancements: Rapid technological advancements in the medical field may render certain products or technologies obsolete, requiring continuous innovation and adaptation.

Escalon Medical Employees

  • 3 Years

  • 5 Years

  • 10 Years

  • 25 Years

  • Max

Escalon Medical Employees
Details
Date
Escalon Medical Employees
Jan 1, 2018
- Employees
Jan 1, 2019
- Employees
Jan 1, 2020
- Employees
Jan 1, 2021
- Employees
Jan 1, 2022
- Employees
Jan 1, 2023
- Employees
Jan 1, 2024
- Employees
Jan 1, 2025
- Employees

Escalon Medical Segments

Escalon Medical Revenue by Segment

  • 3 Years

  • 5 Years

  • 10 Years

  • Max

Sonomed-Escalon
Details
Date
Sonomed-Escalon
Jan 1, 2014
5.42 M USD

Escalon Medical Revenue by Region

  • 3 Years

  • 5 Years

  • Max

Domestic
International
Details
Date
Domestic
International
Jan 1, 2020
5.78 M USD
3.62 M USD

Escalon Medical Eulerpool Fair Value

Details

Fair Value Estimate

What Is Fair Value?

Fair value is an estimate of what a stock is truly "worth" based on its financial fundamentals, independent of the current market price. If the calculated fair value is above the current share price, the stock may be undervalued — and vice versa. This chart shows three different fair value approaches so you can cross-check them against each other.

Earnings-Based Fair Value

Calculated by multiplying the current earnings per share (EPS) by the average historical P/E ratio over a selected multi-year period. The smoothing over several years filters out temporary spikes or dips. If this fair value exceeds the market price, it suggests the stock is cheap relative to its earning power.

Example: Fair Value (Earnings) 2022 = EPS 2022 × Average P/E 2019–2021

Revenue-Based Fair Value

Derived by multiplying revenue per share by the average historical price-to-sales ratio. This method is particularly useful for companies with volatile or temporarily depressed earnings, as revenue tends to be more stable than profits. It answers: "At what price has the market historically valued each dollar of this company's sales?"

Example: Fair Value (Revenue) 2022 = Revenue per Share 2022 × Average P/S 2019–2021

Dividend-Based Fair Value

Calculated by dividing the dividend per share by the average historical dividend yield. This approach is most relevant for mature, consistently dividend-paying companies. If the resulting fair value is higher than the current price, it implies the stock offers a better yield than its historical average.

Example: Fair Value (Dividend) 2022 = Dividend per Share 2022 ÷ Average Yield 2019–2021

How to Use This Chart

When all three fair value lines converge above the current price, it strengthens the case that the stock is undervalued. When they diverge, investigate why — it may indicate a structural shift in margins, payout policy, or growth rate. The forward estimates on the right extend the analysis using projected fundamentals, helping you assess whether the current price already reflects future growth expectations.

Escalon Medical historical P/E ratio, EBIT multiple, and P/S ratio

Escalon Medical annual returns

Details

Annual Return

What This Chart Shows

This chart breaks down 's total annual return into two components: price return (gains or losses from stock price movement) and dividend return (income received from dividend payments). Together, they represent the total return an investor would have earned in each calendar year.

Price Return

Price return measures the percentage change in 's stock price from January 1st to December 31st of each year. Positive bars indicate the stock appreciated; negative bars show a decline. This is the component most investors focus on, but it tells only part of the story — especially for dividend-paying stocks.

Dividend Return

Dividend return represents the income generated from dividends paid during the year, expressed as a percentage of the starting stock price. While it may seem small in any single year (typically 1–4 % for established companies), dividends compound significantly over decades and have historically contributed roughly 40 % of total stock market returns.

What to Look For

Examine how many years showed positive vs. negative returns to gauge consistency. A stock with mostly positive years and small drawdowns suggests lower risk. Also compare 's annual returns to a benchmark index — consistently outperforming the market is a hallmark of a strong investment. Pay attention to the worst years: understanding downside risk is just as important as chasing upside potential.

Escalon Medical shares outstanding

The number of shares of Escalon Medical was 14.25 M in 2025. This indicates how many shares Escalon Medical is divided into. Since shareholders are the owners of a company, each share represents a small portion of the company's ownership.
  • 3 Years

  • 5 Years

  • 10 Years

  • 25 Years

  • Max

Number of stocks
Details
Date
Number of stocks
Jan 1, 2018
14.25 M Stocks
Jan 1, 2019
14.25 M Stocks
Jan 1, 2020
14.25 M Stocks
Jan 1, 2021
14.25 M Stocks
Jan 1, 2022
14.25 M Stocks
Jan 1, 2023
14.25 M Stocks
Jan 1, 2024
14.25 M Stocks
Jan 1, 2025
14.25 M Stocks

Escalon Medical stock splits

In Escalon Medical's history, there have been no stock splits.
Price targets and forecasts for Escalon Medical are not yet available.

Escalon Medical Earnings Estimates & Surprises

DateEPS estimateEPS ActualRevenue EstimatePrice reactionQuarterly report
2/14/2006-0.02USD-7.59 MUSD-2006 Q2
11/14/20050.11USD-7.26 MUSD-2006 Q1
9/29/20050.12USD-7.99 MUSD-2005 Q4
5/16/2005-0.04USD-6.68 MUSD-2005 Q3

Escalon Medical shareholder structure

% Name
0.98815%
DePiano (Richard J Jr)
DePiano (Richard J Jr)
0.00175%
Trusk (C. Todd)
Trusk (C. Todd)
0.00000%
Newton (Charles Carter)
Newton (Charles Carter)

Escalon Medical Beneficial Ownership Filings (SEC 13D/G)

Free Float
98.1%
Float Shares
-
Shares Outstanding
-
StakeHolderFiling
9.99%
Abigail P. Johnson
Abigail P. Johnson
SEC ↗
9.10%
(1) GRT Capital Partners, L.L.C.
(1) GRT Capital Partners, L.L.C.
SEC ↗
7.90%
LPL Financial LLC
LPL Financial LLC
SEC ↗
6.24%
(1) GRT Deep Woods Partners, L.P.
(1) GRT Deep Woods Partners, L.P.
SEC ↗
6.24%
(1) GRT Deep Woods GP, L.L.C.
(1) GRT Deep Woods GP, L.L.C.
SEC ↗
5.70%
Allen Holding Inc.
Allen Holding Inc.
SEC ↗
5.70%
Allen & Company Incorporated
Allen & Company Incorporated
SEC ↗
4.11%
(1) SKK Deep Woods Partners, LP
(1) SKK Deep Woods Partners, LP
SEC ↗
4.11%
(1) SKK Deep Woods GP, LLC
(1) SKK Deep Woods GP, LLC
SEC ↗
4.11%
(1) Shepherd Kaplan Krochuk, LLC
(1) Shepherd Kaplan Krochuk, LLC
SEC ↗

Escalon Medical Executives and Management Board

8 members · avg. age 54 · 13 % women

RD

Richard DePiano (47)

President, Chief Executive Officer, General Counsel, Director · since 2006

224,600.00 USD

Management

MW

Mr. Mark Wallace (44)

Chief Financial Officer, Chief Operating Officer, Chief Accounting Officer

175,000.00 USD

Board of Directors

RD

Mr. Richard DePiano (73)

Chairman of the Board · since 1996

261,427.00 USD
JD

Mr. John Dogum

Director

DJ

Mr. David Jacovini (42)

Director

CT

Mr. C. Todd Trusk

Director

FC

Mr. Fred Choate (69)

Independent Director

LN

Ms. Lisa Napolitano (48)

Independent Director

Escalon Medical Supply Chain

Escalon Medical Supply Chain

Correlation: how closely stock prices move together

Same directionNo relationOpposite
2 companies
#NameTrend
1
Tokai Carbon
Supplier·Customer·Chemicals·JP
0.34
0.48
-0.13
0.68
0.56
2
Air Liquide
Supplier·Chemicals·FR
-0.37
0.57
-0.01
-0.08
-0.47

Frequently asked questions about Escalon Medical

The business model of Escalon Medical Corp is focused on innovative medical devices and pharmaceutical products. The company aims to address unmet medical needs and improve patient outcomes through its product portfolio. Escalon Medical Corp specializes in ophthalmology, offering diagnostic and surgical equipment along with pharmaceuticals for conditions such as glaucoma and diabetic retinopathy. The company's commitment to cutting-edge technologies and a strong presence in the ophthalmic market enables it to provide effective solutions for eye care professionals and patients worldwide. With a comprehensive range of products tailored to meet specific needs, Escalon Medical Corp continues to drive advancements in the field of ophthalmology.

Escalon Medical Corp is primarily active in the medical device industry.

The main competitors of Escalon Medical Corp in the market include companies such as Becton, Dickinson and Company (BD), Johnson & Johnson, Thermo Fisher Scientific, Siemens Healthineers, and Medtronic.

Escalon Medical Corp is a renowned company that specializes in the development and marketing of medical devices for eye care. Founded in 1987, Escalon Medical Corp has a rich history and extensive expertise in ophthalmic diagnostics and surgical products. With a strong focus on innovation and customer satisfaction, the company has built a solid reputation for providing cutting-edge technologies to healthcare professionals worldwide. Escalon Medical Corp's dedication to improving vision care has made it a trusted name in the industry. Over the years, the company's commitment to quality and advancement has contributed to its continued success and growth in the medical technology sector.

Escalon Medical Corp has achieved several significant milestones throughout its history. Some notable achievements include expanding its product portfolio with innovative and high-quality medical devices, establishing a strong presence in the ophthalmic diagnostic imaging market, and successfully launching advanced diagnostic tools. Additionally, the company has demonstrated consistent growth and profitability, earning a reputation for its commitment to delivering cutting-edge healthcare solutions. Escalon Medical Corp has also made substantial investments in research and development, further enhancing its capabilities and staying ahead of industry trends. These accomplishments highlight the company's dedication to advancing healthcare and position it as a trusted leader in the medical device sector.

Escalon Medical Corp is primarily present in the United States.

Escalon Medical Corp represents a commitment to providing innovative and high-quality medical devices and pharmaceuticals. With an emphasis on improving patient care, the company focuses on developing and commercializing products for ophthalmology and other medical specialties. Escalon Medical Corp strives to meet the evolving needs of healthcare professionals by delivering advanced technologies and solutions that enhance diagnostic capabilities and treatment outcomes. The company's corporate philosophy centers around integrity, collaboration, and customer satisfaction, aiming to establish enduring partnerships and foster growth within the healthcare industry.

Converted at the current exchange rate, the Escalon Medical share trades at 0.15 EUR (0.18 USD).

Escalon Medical Corp is an innovative company in the field of medical devices that specializes in the development, manufacturing, and marketing of advanced technologies. The company was founded in 1987 and is headquartered in Wayne, Pennsylvania. Escalon Medical Corp's business model focuses on three main segments: ophthalmic instruments, diagnostic devices, and medical disposables. In the ophthalmic segment, the company offers a wide range of instruments and accessories used by ophthalmologists worldwide. These instruments include eye surgical scissors, forceps, needles, and other tools. Key products in this area also include ultrasound and laser systems for the diagnosis and treatment of retinal diseases such as macular degeneration. In the diagnostic devices segment, Escalon Medical Corp manufactures equipment used by doctors and clinics for disease diagnosis. These devices include retina scanners, tonometers, ultrasound devices, and other highly precise instruments. These diagnostic systems are capable of providing detailed images of the eye or retina, enabling the treating physician to make accurate assessments of the patient's condition and ensure appropriate treatment. The company's medical disposables can be used in medical laboratories and clinical practice. These include a range of blood lancets, syringes, medical tubing, infusion bags, and other single-use devices. These products are important for ensuring optimal hygiene in medical facilities. In terms of marketing, the company focuses on various strategies. For example, it has established a network of distribution partners to bring a broad range of products to the market. Additionally, the company also collaborates closely with key organizations such as the American Optometric Association or the Association for Research in Vision and Ophthalmology. Escalon Medical Corp also works on selling its products directly to clinics, hospitals, and medical practices. The company's business model is based on the development and provision of high-quality medical instruments and accessories. It is constantly striving to improve its production processes and technologies to enhance its competitiveness in the market. In summary, Escalon Medical Corp's business model offers a wide range of products and services in the field of ophthalmic instruments, diagnostic devices, and medical disposables. The company pursues a clear and comprehensive strategy to bring its products to the market directly and indirectly, while always increasing its high quality, customer focus, and innovation capability.

The revenue cannot currently be calculated for Escalon Medical.

The profit cannot currently be calculated for Escalon Medical.

The P/E ratio cannot be calculated for Escalon Medical at the moment.

The P/S cannot be calculated for Escalon Medical currently.

The Eulerpool Quality Score for Escalon Medical is 3/10.

The ISIN of Escalon Medical is US2960743050. The ISIN (International Securities Identification Number) is a globally unique identifier for securities.

The WKN of Escalon Medical is 884822. The WKN (Wertpapierkennnummer) is a six-digit German security identification number.

The ticker of Escalon Medical is ESMC. The ticker symbol is used to trade Escalon Medical shares on the stock exchange.

Escalon Medical paid dividends every year for the past 0 years.

Escalon Medical is assigned to the 'Health' sector.

The dividends of Escalon Medical are distributed in USD.